Next-generation sequencing in hematologic malignancies: what will be the dividends?

Jason D Merker1, Anton Valouev, Jason Gotlib

  • 1Department of Pathology, Stanford University School of Medicine, Stanford, CA 94304, USA.

Summary

High-throughput DNA sequencing offers new insights into blood cancers, aiding in understanding disease development and treatment response. These advancements promise more personalized therapies for patients with hematologic neoplasms.